Recently, chronic vitamin D receptor stimulation by cholecalciferol therapy has been shown to blunt systemic RAS activity in essential hypertensive patients with hypovitaminosis D under constant salt intake and free from drugs interfering with RAS [84]. This evidence concerns the gene VDR and essential hypertension.